2024-08-05 10:45:00
According to a report by the European Cancer Organization (Source 1), France lags behind in cancer prevention and screening.
Certain associations and collectives are also working to change this situation. This is a collective situation”we can be together”, created and backed by pharmaceutical giant AstraZeneca.
Pilot studies aimed at conducting organized screening
In a press release (source 2), the group said it hopes to raise awareness about the use of low-dose scans for lung cancer screening. He recalled, Organized lung cancer screeningAlready implemented in several countries and the subject of a pilot study in France given its potential universality.
“Initiated in 2016 by Dr. Olivier Leleu, a member of the “Ensemble Nous Poumons” collective, and conducted in the Somme department, the DEP KP80 study is the first sector-scale real-life pilot study in France, confirming the feasibility and effectiveness of lung transplantation.Dose CT for cancer screening”, designates the collective, adding “The study included more than 1,300 participants who were smokers or former smokers aged 55 to 74”.
This project is among 15 ongoing pilot projects in France that will provide evidence of the effectiveness and feasibility of organized screening.
Elsewhere in Europe, other countries are conducting such studies. This is the case in Italy, Hungary, Slovakia, Germany and the UK. Croatia, Poland and the Czech Republic have also organized screenings across the country.
The collective noted in its press kit AI “Can also supplement medical expertise To detect lung cancer early”.
Lung cancer is often diagnosed too late France’s deadliest cancerit is expected that there will be 52,777 new cases in 2023 and more than 33,000 deaths per year.
1722861601
#Lung #cancer #Find #group #France #working #speed #screening
